शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEPANCHSHEEL ORGANICS LTD.· Pharmaceuticals & BiotechnologyCriticalNegative
Announced Mon, 3 Aug, 2026 · 23:31 IST

Promoter and MD Mr. Mahendra Turakhia passes away

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹113.00
prior close
₹119.90
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.7% vs market
Pharmaceuticals peers, median of 165sector+0.0%-0.3% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.2
10m
-1.2
15m
-1.2
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3+0.4-0.7+0.0-0.3
Next day
+1.7+1.7-0.0+0.0+1.7
2d
+0.1+2.1-2.0+0.2-0.0
3d
-0.7+2.1-2.8+0.5-1.2
4d
+4.4+2.1+2.3+0.6+3.8
5d
+5.8+1.9+3.9+0.8+5.0
1w
+9.2+2.4+6.8+0.4+8.8
15d
+2.7+3.0-0.4+0.5+2.2
1m
-6.6+3.7-10.4+1.1-7.8
2m
-8.1+1.6-9.6+2.1-10.2
3m
-10.2-2.7-7.5-2.4-7.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Panchsheel Organics informed BSE about the sudden demise of Mr. Mahendra Abhaychand Turakhia, Executive Whole Time Director, Promoter and Managing Director, on August 01, 2026. He held 21,20,672 shares representing 16.10 percent stake in the company. The board called his loss irreparable and expressed condolences to his family. Required disclosures under SEBI LODR Regulation 30 have been filed.

Likely market impact

Loss of key promoter and MD may create leadership uncertainty and near term volatility for the stock.